India is home to over 100 million people with diabetes and approximately 250 million classified as obese or overweight.[15] What makes the situation uniquely dangerous is the Thin-Fat Indian paradox: South Asians tend to accumulate more visceral (belly) fat, liver fat, and less lean muscle mass at lower body weights than Western populations.[8][9][10] While GLP-1 medications are a global phenomenon, they are particularly critical for the Thin-Fat Indian phenotype
Users of GLP-1 medications often report significant changes in their food preferences and cravings
Important Information This program is provided under medical supervision only
Tailored sessions aim to restore intracellular health, reduce oxidative damage to DNA, proteins, and lipids, and support foundational detox systems
Maleki I, Rastgar A, Hosseini V, et al